Russia’s Enteromix cancer vaccine, developed using mRNA technology, has shown 100 percent efficacy in early trials. Not yet approved for clinical use, it offers a personalised approach to training the immune system to target cancer cells
  • Guidy@lemmy.worldEnglish
    6·
    1 个月前

    Eh if they come up with a reliable way to defeat it I’d say it’s worth it.